##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 WASHINGTON, D.C. 20549
 FORM 10-Q/A
 Amendment No. 1
 þ
    
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
 FOR THE QUARTERLY PERIOD ENDED June 30, 2009
 o
    
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 FOR THE TRANSITION PERIOD FROM
 TO
 COMMISSION FILE NUMBER: 001-32360
 AKORN, INC.
  LOUISIANA
    
    72-0717400(State or Other Jurisdiction of
    
    (I.R.S. EmployerIncorporation or Organization)
    
    Identification No.)1925 W FIELD CT STE 300LAKE FOREST, ILLINOIS
    
    60045(Address of Principal Executive Offices)
    
    (Zip Code)
 (847) 279-6100
(Registrants telephone number, including area code)
  þ o
  o o
  Large accelerated filero
    
    Accelerated filerþ
    
    Non-accelerated filero
    
    Smaller reporting companyo
  Yes o No þ




---



TABLE OF CONTENTS  ITEM 6. EXHIBITSSIGNATURESEX-32.1EX-32.2    Table of Contents  EXPLANATORY NOTE
   
 ITEM 6. EXHIBITS
 W
 Exhibit No.
    
    Description(4.1)
    
    Akorn, Inc. Common Stock Purchase Warrant, dated April 13, 2009, in favor of EJ Funds
LP, incorporated by reference to Exhibit 4.1 to Akorn, Inc.s report on Form 8-K
filed on April 17, 2009.(4.2)
    
    Modification, Warrant and Investor Rights Agreement, dated April 13, 2009, among
Akorn, Inc., Akorn (New Jersey), Inc., and EJ Funds LP, incorporated by reference to
Exhibit 4.2 to Akorn, Inc.s report on Form 8-K filed on April 17, 2009.(4.3)
    
    Akorn, Inc. Common Stock Purchase Warrant, dated April 15, 2009, in favor of John N.
Kapoor Trust dated 9/20/89, incorporated by reference to Exhibit 4.1 to Akorn, Inc.s
report on Form 8-K filed on April 21, 2009.(10.1)
    
    Credit Agreement dated January 7, 2009, by and between Akorn, Inc., Akorn (New
Jersey), Inc. and General Electric Capital Corporation, incorporated by reference to
Exhibit 10.1 to Akorn Inc.s report on Form 8-K filed on January 9, 2009.(10.2)W
    
    Letter Agreement dated March 27, 2009 between Akorn, Inc. and Massachusetts Biologic
Laboratories of the University of Massachusetts Medical School, incorporated by
reference to Exhibit 10.72 to Akorn, Incs report on Form 10-K for the fiscal year
ended December 31, 2008, filed on March 30, 2009.(10.3)
    
    Memorandum of Agreement, dated March 31, 2009, among EJ Funds LP, Akorn Inc., and
Akorn (New Jersey), Inc., incorporated by reference to Exhibit 10.1 to Akorn Inc.s
report on Form 8-K filed on April 6, 2009.(10.4)
    
    Assignment, dated March 31, 2009, among General Electric Capital Corporation, EJ
Funds LP, Akorn, Inc., and Akorn (New Jersey), Inc., incorporated by reference to
Exhibit 10.2 to Akorn Inc.s report on Form 8-K filed on April 6, 2009.(10.5)
    
    Reimbursement and Warrant Agreement, dated April 15, 2009, among Akorn, Inc. Akorn
(New Jersey), Inc., John N. Kapoor Trust dated 09/20/89, and EJ Funds LP,
incorporated by reference to Exhibit 10.1 to Akorn Inc.s report on Form 8-K filed on
April 21, 2009.




---



##### Table of Contents



Exhibit No.
    
    Description(10.6)W
    
    Settlement Agreement, dated April 15, 2009, between Akorn, Inc. and Massachusetts
Biologic Laboratories of the University of Massachusetts Medical School, incorporated
by reference to Exhibit 10.2 to Akorn Inc.s report on Form 8-K filed on April 21,
2009.(10.7)W
    
    Fourth Amendment to Exclusive Distribution Agreement, dated April 15, 2009, between
Akorn, Inc. and Massachusetts Biologic Laboratories of the University of
Massachusetts Medical School, incorporated by reference to Exhibit 10.2 to Akorn
Inc.s report on Form 8-K filed on April 21, 2009.(31.1)
    
    Certification of Chief Executive Officer pursuant to Rule 13a-14(a), incorporated by
reference to Exhibit 31.1 to Akorn
Inc.s report on Form 10-Q for the period ended June 30, 2009.(31.2)
    
    Certification of Chief Financial Officer pursuant to Rule 13a-14(a), incorporated by
reference to Exhibit 31.2 to Akorn
Inc.s report on Form 10-Q for the period ended June 30, 2009.(32.1)*
    
    Certification of Chief Executive Officer pursuant to 18 U.S.C. § 1350.(32.2)*
    
    Certification of Chief Financial Officer pursuant to 18 U.S.C. § 1350.




---



##### Table of Contents



SIGNATURES
  AKORN, INC./s/  Timothy A. DickTimothy A. DickSr. Vice President, Chief Financial
Officer
(Duly Authorized and Principal Financial Officer)